Genasense oblimersen: Phase I/II started

GNTA began an open-label Phase I/II trial of IV Genasense plus Abraxane and

Read the full 132 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE